Background There is an increasing body of evidence associating traditional cardiovascular
risk factors with atrial fibrillation (AF), but the relationship between blood lipid profiles and …

Despite great progress in treating atrial fibrillation (AF), especially with the development of
increasingly effective invasive techniques for AF ablation, many unanswered questions …

Background The most prevalent sustained arrhythmia in medical practice, atrial fibrillation
(AF) is closely associated with a high risk of cardiovascular disease. Nevertheless, the risk of …

Traditional anti-arrhythmic drugs are classified by the Vaughan-Williams classification
scheme based on their mechanisms of action, which includes effects on receptors and/or ion …

Objective: Assessment of asymptomatic organ damage in the management of hypertension
includes low (< 0.9) ankle brachial index (ABI) values. No recommendations are given for …

Objective To conduct a systematic review and meta-analysis to compare the effects of statins
and placebo on systolic blood pressure (SBP) and diastolic blood pressure (DBP) in patients …

This study aimed to assess atrial fibrillation (AF) incidence and predictive factors in
hypertensive patients and to formulate an AF risk assessment score that can be used to …

Aim To investigate the upstream therapeutic effects of fluvastatin and valsartan on
hypertensive patients with non‐permanent atrial fibrillation (AF). Methods A total of 189 …

The relationship of dyslipidemia with atrial fibrillation (AF)-related stroke is not clear. The
question whether patients with AF-related stroke should receive lipid lowering agents …

Anti-arrhythmic drugs are traditionally categorized using the Vaughan-Williams
classification. Several medications that were originally licensed for non-arrhythmic …